Burden of hidradenitis suppurativa: a systematic literature review of patient reported outcomes

AB Kimball, J Kirby, JR Ingram, T Tran, I Pansar… - Dermatology and …, 2024 - Springer
Introduction Hidradenitis suppurativa (HS) has a profound negative impact on patients'
health-related quality of life (HRQoL). Here we summarize the evidence on HRQoL and …

Hidradenitis Suppurativa: A Review of the Biologic and Small Molecule Immunomodulatory Treatments

N Chiang, R Alhusayen - Journal of Cutaneous Medicine …, 2024 - journals.sagepub.com
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that presents as
painful, deep-seated nodules, sinus tracts, and abscesses in about 1% of the population …

Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and …

CC Zouboulis, T Passeron, D Pariser… - British Journal of …, 2024 - academic.oup.com
Background Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease
associated with a substantial disease burden. Secukinumab has previously been reported to …

Adalimumab dose intensification in hidradenitis suppurativa: effectiveness and safety results of a multicentre study

EM Sánchez Martínez, G Murray… - British Journal of …, 2021 - academic.oup.com
1 Bondavalli D, White SM, Steer A et al. Is cardiac rhabdomyoma a feature of Birt Hogg
Dubé syndrome? Am J Med Genet A 2015; 167: 802–4. 2 Balakumar R, Farr MRB …

Hidradenitis suppurativa and suicide risk: a multivariate analysis in a disease with a high psychological burden

J Ortiz-Álvarez, JC Hernández-Rodríguez… - Archives of …, 2023 - Springer
Background Hidradenitis suppurativa (HS) is a disorder that can lead to serious sequelae
and important comorbidities. It has been associated with different mental health conditions …

Comprehensive codified algorithms to identify the underestimated burden of hidradenitis suppurativa in the United States

JR Ingram, Y Geissbühler, J Darcy, S Foley… - Dermatology and …, 2024 - Springer
Introduction Hidradenitis suppurativa (HS) is a painful, inflammatory skin disease associated
with a high disease burden and long diagnostic delay. Prevalence estimates of HS vary …

Noticeability of vitiligo is in the eye of the beholder.

AG Pandya, K Ezzedine - British Journal of Dermatology, 2022 - search.ebscohost.com
Noticeability of vitiligo is in the eye of the beholder Page 1 Noticeability of vitiligo is in the eye of
the beholder DOI: 10.1111/bjd.21779 Linked Article: Batchelor et al. Br J Dermatol 2022; …

Biologic use in hidradenitis suppurativa: patient perspectives and barriers

DR De, T Shih, D Fixsen, B Brooks… - Journal of …, 2022 - Taylor & Francis
Introduction Hidradenitis suppurativa (HS) is an inflammatory dermatosis for which the
treatment paradigm is rapidly expanding. We aimed to identify HS patient perspectives and …

Klinische, pathologische und molekulare Biomarker der Hidradenitis suppurativa/Acne inversa

M von Laffert, RE Hunger, AA Navarini, CC Zouboulis - Der Hautarzt, 2021 - Springer
Zusammenfassung Die Hidradenitis suppurativa/Acne inversa ist eine vernarbende
Erkrankung der Intertrigines, die heute intensiv beforscht wird. Durch das verbesserte …

Implementing evidence‐based strategies to optimize the journey of patients with hidradenitis suppurativa

T Tzellos - British Journal of Dermatology, 2022 - search.ebscohost.com
Implementing evidence-based strategies to optimize the journey of patients with hidradenitis
suppurativa Page 1 survey among patients and clinicians on outcomes in vitiligo trials. Br J …